Skip to content

A study to evaluate the Moisturization Properties of Test Product in Healthy Adult Human Participants.

A Single Center, Application Site Randomized, Blinded, Moisturization Study to Evaluate the Moisturization Properties of Test Products in Healthy Adult Human Participants. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081637
Enrollment
36
Registered
2025-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Alverise Bio Instant & Intensive Moisturizing Lotion: Approx. 50 mg, Neat, Single application on volar forearms Control Intervention1: Control Site: No product application

Sponsors

Encore Healthcare Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy adult males and non-pregnant/non-lactating females (1:1) with age 18 to 65 years (both inclusive at the time of consent). 2. Participants having good general health as determined by the Investigator on the basis of medical history. 3. Female participants of childbearing potential must have a negative urine pregnancy test performed at enrollment visit. 4. Participants willing to follow all the acceptable forms of contraception as applicable.

Exclusion criteria

Exclusion criteria: 1. Participants using Body milk /lotion / cream, cosmetics or any other body moisturizing product 3-5 days prior to study. 2. Participants who are on systemic medication or any medications would compromise the study. 3. Chronic illness which may influence the cutaneous state. 4. Participants having history of diabetes. 5. Participants with known allergy or sensitivity to cosmetic products and/or any ingredients of the test product.

Design outcomes

Primary

MeasureTime frame
Instrumental and Dermatological AssessmentTimepoint: Day 01 [(Before application (i.e., baseline) and after application at 01 hour (plus 15 mins), 04 hours (plus 15 mins) and 06 hours (plus 15 mins)] and on Day 02 [24 hours (plus 15 mins) after application].

Secondary

MeasureTime frame
Subjective EvaluationTimepoint: Day 02 [24 hours plus 15 mins) after application]

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

ssethi@cliantha.com9825784942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026